New drug enhances radiation treatment for brain cancer in preclinical studies
A novel drug may help increase the effectiveness of radiation therapy for the most deadly form of brain cancer, report scientists at Virginia Commonwealth University Massey Cancer Center. In mouse...
Curie-Cancer and Roche strengthen partnership to fast-track the development of new molecules
Curie-Cancer and Roche strengthen partnership to fast-track the development of new molecules Curie-Cancer and Roche build on four years partnership by increasing translational research programs,...
OHSU research team successfully converts human skin cells into embryonic stem cells
The breakthrough marks the first time human stem cells have been produced via nuclear transfer and follows several unsuccessful attempts by research groups worldwide PORTAND, Ore. – Scientists...
Preclinical Research Shows PLX Cells May be Effective in Treating Preeclampsia
HAIFA, Israel, May 13, 2013 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PLTR), a leading developer of placenta-based cell therapies, announced today its PLacental eXpanded...
Scientists Find Key to Gene-Silencing Activity
LA JOLLA, CA – May 9, 2013 – A team led by scientists at The Scripps Research Institute (TSRI) has found how to boost or inhibit a gene-silencing mechanism that normally serves as a major...
Receptor proteins could hold clues to antibiotic resistance in MRSA
13 Mary 2103--Imperial College London Scientists at Imperial College London have identified four new proteins that act as receptors for an essential signalling molecule in bacteria such as MRSA. The...
Tumor-Activated Protein Promotes Cancer Spread
Researchers at the University of California, San Diego School of Medicine and UC San Diego Moores Cancer Center report that cancers physically alter cells in the lymphatic system – a network of...
Salk scientists develop drug that slows Alzheimer's in mice
Findings may lead to first therapeutic drug to treat advanced Alzheimer's LA JOLLA, CA---A drug developed by scientists at the Salk Institute for Biological Studies, known as J147, reverses...
Acorda Therapeutics Announces Data Showing Dalfampridine Improves Motor Function in Preclinical Mode
ARDSLEY, N.Y.--(BUSINESS WIRE)-- Acorda Therapeutics, Inc. (Nasdaq:ACOR) today announced that data showing treatment with dalfampridine improved motor function in a preclinical model of post-stroke...
Could eating peppers prevent Parkinson's?
Dietary nicotine may hold protective key New research reveals that Solanaceae—a flowering plant family with some species producing foods that are edible sources of nicotine—may provide a...
Breakthrough In The Understanding Of How Pancreatic Cancer Cells Ingest Nutrients Points To New Drug Target
In a landmark cancer study published online in Nature, researchers at NYU School of Medicine have unraveled a longstanding mystery about how pancreatic tumor cells feed themselves, opening up new...
Cocaine vaccine passes key testing hurdle
New anti-cocaine vaccine research shows drug can't reach the brain, human clinical trials on the horizon NEW YORK (May 10, 2013) -- Researchers at Weill Cornell Medical College have successfully...
Rejuvenating hormone found to reverse symptoms of heart failure
Heart failure is one of the most debilitating conditions linked to old age, and there are no specific therapies for the most common form of this condition in the elderly. A study published by Cell...
Emergent BioSolutions Presents Preclinical Efficacy Data on ES414 Its Lead ADAPTIR Bispecific Therapeutic for Prostate Cancer
Emergent BioSolutions Presents Preclinical Efficacy Data on ES414 Its Lead ADAPTIR Bispecific Therapeutic for Prostate Cancer ROCKVILLE, Md.--(BUSINESS WIRE)-- Emergent BioSolutions Inc. (NYS:EBS)...
Transgene Presents Promising Pre-Clinical Data on TG1050 to Treat Chronic HBV at EASL 2013
STRASBOURG, France--(BUSINESS WIRE)-- Regulatory News: Transgene SA (TNG.PA) (Euronext Paris: FR0005175080), a biopharmaceutical company that develops targeted immunotherapy products to treat major...
MAKING CANCER LESS CANCEROUS
Blocking a single gene renders tumors less aggressive, Johns Hopkins researchers find Researchers at Johns Hopkins have identified a gene that, when repressed in tumor cells, puts a halt to cell...
Discovery Helps Show How Breast Cancer Spreads
Newswise — Researchers at Washington University School of Medicine in St. Louis have discovered why breast cancer patients with dense breasts are more likely than others to develop aggressive...
Effects of stress on brain cells offer clues to new anti-depressant drugs
Research from King's College London reveals the detailed mechanism behind how stress hormones reduce the number of new brain cells - a process considered to be linked to depression. The...
Afraxis, Inc. and Servier Announce a Collaboration on ESP Platform for Drug Discovery in Central Nervous System Disorders
SAN DIEGO and PARIS, April 30, 2013 -- /PRNewswire/ -- Afraxis, Inc. ("Afraxis") and Institut de Recherches Servier ("Servier") announced a non-exclusive platform collaboration...
New mouse model confirms how type 2 diabetes develops
Researchers at Lund University in Sweden have developed a new mouse model that answers the question of what actually happens in the body when type 2 diabetes develops and how the body responds to...
